Literature DB >> 15618664

CYP3A4 gene polymorphisms influence testosterone 6beta-hydroxylation.

Norie Murayama1, Takahiro Nakamura, Mayumi Saeki, Akiko Soyama, Yoshiro Saito, Kimie Sai, Seiichi Ishida, Osamu Nakajima, Masaya Itoda, Yasuo Ohno, Shogo Ozawa, Jun-Ichi Sawada.   

Abstract

Three non-synonymous single nucleotide polymorphisms (SNPs) in the CYP3A4 gene were found in 34 cell lines derived from Japanese individuals. These three SNPs (T185S, L293P, and T363M)(1) have been previously reported, but little is known about the effect that these polymorphisms, especially T185S, have on catalytic activity. We measured testosterone hydroxylation in wild-type CYP3A4 and these three variants using a mammalian expression system. Testosterone 6beta-, 2beta-, and 15beta-hydroxylations by the variant CYP3A4 forms T363M (<40%) and T185S (<60%) were reduced as compared with the wild-type in transient expression assays. L293P was similar to the wild-type in testosterone 6beta- and 2beta-hydroxylase activities. Western blot analysis confirmed lower amounts of CYP3A4 protein in the T363M and T185S variants than in the wild-type. Interestingly, Northern blot analysis showed no significant difference among mRNA levels between the wild-type and variants. These results suggest that the T363M and T185S substitutions in CYP3A4 affect either protein expression or stability. These established cell lines provided useful CYP3A4 SNP information in the Japanese.

Entities:  

Year:  2002        PMID: 15618664     DOI: 10.2133/dmpk.17.150

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  5 in total

Review 1.  Pharmacogenomics of CYP3A: considerations for HIV treatment.

Authors:  Sukhwinder S Lakhman; Qing Ma; Gene D Morse
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

2.  Comparison of the inhibitory profiles of itraconazole and cimetidine in cytochrome P450 3A4 genetic variants.

Authors:  Takeshi Akiyoshi; Takashi Saito; Saori Murase; Mitsue Miyazaki; Norie Murayama; Hiroshi Yamazaki; F Peter Guengerich; Katsunori Nakamura; Koujirou Yamamoto; Hisakazu Ohtani
Journal:  Drug Metab Dispos       Date:  2011-01-06       Impact factor: 3.922

3.  Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers.

Authors:  Liliana Mancio-Silva; Heather E Fleming; Alex B Miller; Stuart Milstein; Abigail Liebow; Patrick Haslett; Laura Sepp-Lorenzino; Sangeeta N Bhatia
Journal:  Cell Metab       Date:  2019-03-05       Impact factor: 27.287

4.  The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy.

Authors:  Danxin Wang; Wolfgang Sadee
Journal:  J Pers Med       Date:  2012-10-29

5.  Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro.

Authors:  Dong-Sheng Ouyang; Wei-Hua Huang; Dan Chen; Wei Zhang; Zhi-Rong Tan; Jing-Bo Peng; Yi-Cheng Wang; Ying Guo; Dong-Li Hu; Jian Xiao; Yao Chen
Journal:  Chin Med       Date:  2016-03-22       Impact factor: 5.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.